AIHTA - Publications - Search - Toripalimab (Loqtorzi®) in combination with cisplatin and gemcitabine for the first-line treatment of recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma (NPC)

Rothschedl, E. and Grössmann, N. (2024): Toripalimab (Loqtorzi®) in combination with cisplatin and gemcitabine for the first-line treatment of recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma (NPC). Fact Sheet Nr. 184.

[thumbnail of Fact Sheet Nr.184.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
251kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WV Otolaryngology > WV 300-358 Nose and paranasal sinuses
WV Otolaryngology > WV 400-440 Pharyngeal region
Language:English
Series Name:Fact Sheet Nr. 184
Deposited on:24 Sep 2024 10:25
Last Modified:24 Sep 2024 10:25

Repository Staff Only: item control page